Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Jason W. Locasale(Duke University), Matthew G. Vander Heiden(Broad Institute), Andrea L. Richardson(Johns Hopkins University), Edouard Mullarky(Cornell University), Mika Sasaki(Center for Systems Biology), Azra H. Ligon(Brigham and Women's Hospital), John M. Asara(Beth Israel Deaconess Medical Center), Rameen Beroukhim(Broad Institute), Christian M. Metallo(Salk Institute for Biological Studies), Joan S. Brugge(Harvard University), Taru Muranen(Beth Israel Deaconess Medical Center), Gregory J. Heffron(Harvard University), Matthew Meyerson(Broad Institute), Lewis C. Cantley(Harvard University), Tamar Melman(Harvard University), Hadar Sharfi(Harvard University), Dimitrios Anastasiou(The Francis Crick Institute), Katherine Mattaini(Tufts University), Adam J. Bass(Dana-Farber Cancer Institute), Costas A. Lyssiotis(University of Michigan), Atsuo T. Sasaki(University of Cincinnati Medical Center), Natalie I. Vokes(The University of Texas MD Anderson Cancer Center), Gerhard Wagner(Harvard University), Alexandra Grassian(Blueprint Medicines (United States)), Lynda Chin(American Productivity and Quality Center), Gregory Stephanopoulos(Massachusetts Institute of Technology)
Cited by 1,122
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k